Amesite Inc.

AI-generated fair value estimate for this company.

Method: Net financial asset value plus modest going-concern premium: $2.3M cash (no debt) across 6.55M shares outstanding = $0.351/share, plus a $0.05/share discretionary premium for its early-stage but revenue-generating NurseMagic AI platform (TTM revenue ~$341K, up 313.6% YoY off a small base).

Reasoning: Amesite is a micro-cap, pre-scale technology company with real but very small revenue and a limited cash runway, so a standard multi-year DCF is not meaningful given the tiny revenue base and high estimation error; anchoring to its verifiable net cash position with a small discretionary premium for its growing product traction is the most defensible, non-speculative approach.